Contrasting Nexeon Medsystems (OTCMKTS:NXNN) & QT Imaging (NASDAQ:QTI)

QT Imaging (NASDAQ:QTIGet Free Report) and Nexeon Medsystems (OTCMKTS:NXNNGet Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk.

Analyst Recommendations

This is a breakdown of current ratings and price targets for QT Imaging and Nexeon Medsystems, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QT Imaging 1 0 1 0 2.00
Nexeon Medsystems 0 0 0 0 0.00

Given Nexeon Medsystems’ higher possible upside, analysts clearly believe Nexeon Medsystems is more favorable than QT Imaging.

Volatility and Risk

QT Imaging has a beta of -0.1, suggesting that its share price is 110% less volatile than the S&P 500. Comparatively, Nexeon Medsystems has a beta of 6.98, suggesting that its share price is 598% more volatile than the S&P 500.

Profitability

This table compares QT Imaging and Nexeon Medsystems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
QT Imaging -201.67% N/A -184.12%
Nexeon Medsystems N/A N/A N/A

Insider and Institutional Ownership

24.2% of QT Imaging shares are held by institutional investors. 28.8% of QT Imaging shares are held by company insiders. Comparatively, 61.2% of Nexeon Medsystems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares QT Imaging and Nexeon Medsystems”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
QT Imaging $4.88 million 13.52 -$8.98 million ($2.54) -2.18
Nexeon Medsystems N/A N/A N/A N/A N/A

Nexeon Medsystems has lower revenue, but higher earnings than QT Imaging.

Summary

Nexeon Medsystems beats QT Imaging on 5 of the 9 factors compared between the two stocks.

About QT Imaging

(Get Free Report)

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.

About Nexeon Medsystems

(Get Free Report)

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.

Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.